These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 26816105)

  • 21. Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.
    Fleckenstein J; Petroff A; Schäfers HJ; Wehler T; Schöpe J; Rübe C
    BMC Cancer; 2016 Jun; 16():348. PubMed ID: 27255302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of an Adjusted Prognosis Analysis Model for Initially Diagnosed Non-Small-Cell Lung Cancer With Brain Metastases From Sun Yat-Sen University Cancer Center.
    Dinglin XX; Ma SX; Wang F; Li DL; Liang JZ; Chen XR; Liu Q; Zeng YD; Chen LK
    Clin Lung Cancer; 2017 May; 18(3):e179-e186. PubMed ID: 28185793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC).
    Putora PM; Ess S; Panje C; Hundsberger T; van Leyen K; Plasswilm L; Früh M
    Clin Exp Metastasis; 2015 Feb; 32(2):143-9. PubMed ID: 25628027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External validation of the lung-molGPA to predict survival in patients treated with stereotactic radiotherapy for brain metastases of non-small cell lung cancer.
    Crouzen JA; Mast ME; Hakstege M; Broekman MLD; Baladi C; Mertens BJA; Nandoe Tewarie RDS; Kerkhof M; Vos MJ; Maas KW; Souwer ETD; Wiggenraad RGJ; van der Voort van Zyp NCMG; Kiderlen M; Petoukhova AL; Zindler JD
    Radiother Oncol; 2024 Sep; 198():110405. PubMed ID: 38925263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosurgery for brain metastases from primary lung carcinoma.
    Hoffman R; Sneed PK; McDermott MW; Chang S; Lamborn KR; Park E; Wara WM; Larson DA
    Cancer J; 2001; 7(2):121-31. PubMed ID: 11324765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
    Nieder C; Andratschke N; Grosu AL; Molls M
    Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
    Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
    Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors.
    Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
    J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
    Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
    Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients.
    Abrahams JM; Torchia M; Putt M; Kaiser LR; Judy KD
    J Neurosurg; 2001 Oct; 95(4):595-600. PubMed ID: 11596953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resection of isolated brain metastases in non-small cell lung cancer (NSCLC) patients - evaluation of outcome and prognostic factors: A retrospective multicenter study.
    Fuchs J; Früh M; Papachristofilou A; Bubendorf L; Häuptle P; Jost L; Zippelius A; Rothschild SI
    PLoS One; 2021; 16(6):e0253601. PubMed ID: 34181677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.
    Motta M; del Vecchio A; Attuati L; Picozzi P; Perna L; Franzin A; Bolognesi A; Cozzarini C; Calandrino R; Mortini P; di Muzio N
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e463-8. PubMed ID: 21530098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole brain radiotherapy-based combined modality treatment of brain metastases from non-small cell lung cancer: a retrospective analysis of prognostic factors.
    Xiang Z; Chen J; Zhang H; Shen L; Wei Q
    Oncol Res Treat; 2015; 38(1-2):35-40. PubMed ID: 25634677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival after whole brain radiotherapy for brain metastases from lung cancer and breast cancer is poor in 6325 Dutch patients treated between 2000 and 2014.
    Jeene PM; de Vries KC; van Nes JGH; Kwakman JJM; Wester G; Rozema T; Braam PM; Zindler JD; Koper P; Nuyttens JJ; Vos-Westerman HA; Schmeets I; Niël CGHJ; Hutschemaekers S; van der Linden YM; Verhoeff JJC; Stalpers LJA
    Acta Oncol; 2018 May; 57(5):637-643. PubMed ID: 29276848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer.
    Saitoh Y; Fujisawa T; Shiba M; Yoshida S; Sekine Y; Baba M; Iizasa T; Kubota M
    Lung Cancer; 1999 May; 24(2):99-106. PubMed ID: 10444060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in patients with non-small cell lung carcinoma and brain metastases: a Malaysian perspective.
    Tang WH; Alip A; Saad M; Phua VC; Chandran H; Tan YH; Tan YY; Kua VF; Wahid MI; Tho LM
    Asian Pac J Cancer Prev; 2015; 16(5):1901-6. PubMed ID: 25773842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.
    Kong DS; Lee JI; Nam DH; Park K; Kim JH; Kim JG; Park JO; Park K
    J Korean Med Sci; 2006 Jun; 21(3):527-32. PubMed ID: 16778400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.